10X Genomics Inc: Wall Street Divided on Biotech Stock’s Future Amid Market Volatility
10X Genomics Inc. is at a crossroads, with Wall Street analysts offering conflicting views on its future, as some predict a potential 55.85% rally while others warn of deeper systemic issues.
3 minutes to read